Moreover, quercetin-3-O-glucuronide could act also as a competitive antagonist for β2-AR, inhibiting the binding of [3H]-NA to β2-AR in human breast adenocarcinoma cells MDA-MB-231. This evidence concerns the gene ADRB2 and breast adenocarcinoma.